Eton, David T. http://orcid.org/0000-0001-8715-1511
Linzer, Mark
Boehm, Deborah H.
Vanderboom, Catherine E.
Rogers, Elizabeth A.
Frost, Marlene H.
Wambua, Mike
Vang, Miamoua
Poplau, Sara
Lee, Minji K.
Anderson, Roger T.
Funding for this research was provided by:
National Institute of Nursing Research, National Institutes of Health (R01NR015441)
Article History
Received: 11 August 2020
Accepted: 19 October 2020
First Online: 28 October 2020
Ethics approval and consent to participate
: The patient interviews and provider surveys used to winnow PETS items in Phase I were approved as a minimal risk study by the Hennepin Healthcare IRB under HSR #16–4200. The Phase II survey study to pilot test the Brief PETS measure conducted at Hennepin County Medical Center was approved by the Hennepin Healthcare IRB under HSR #17–4404. The use of prospective survey data from the study of participants of the Rochester Epidemiology Project (REP) was approved by the IRBs of the Mayo Clinic (14–008629) and Olmsted Medical Center (022-OMC-16). These two institutions are co-administrators of the REP. For all aspects of the study signed informed consent was not required as the study was approved as minimal risk with oral consent only (i.e., waiver of consent documentation approved). Oral consent was provided in the form of a cover letter describing the study procedures with consent implied by the return of a completed survey.
: Not applicable.
: The authors declare that they have no competing interests.